Vivos Therapeutics, Inc. - 8-K Filing
Vivos Therapeutics acquires minority stake and co-ownership rights in SOD Sciences' pseudohypoxia test for $12M in preferred stock. (Items: 1.01 Entry into a Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 3.02 Unregistered Sales of Equity Securities, 5.03 below)
Tickers: $VVOS